Spots Global Cancer Trial Database for Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies
Official Title: Characterization of Mechanism of Response to PD-1 Blockade in NSCLC: A Pilot Study
Study ID: NCT03877250
Conditions
Study Description
Brief Summary: The purpose of this study is to attempt to obtain an on-treatment biopsy in participants with non-small cell lung cancer who are receiving standard treatment with a drug that targets the PD-1 or PD-L1 protein.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Memoral Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge, New Jersey, United States
Memoral Sloan Kettering Monmouth (Consent and Follow up), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk (Consent Only), Commack, New York, United States
Memoral Sloan Kettering Westchester (Consent & Follow Up), Harrison, New York, United States
Memorial Sloan - Kettering Cancer Center (Consent and follow-up), New York, New York, United States
Contact Details
Name: Matthew Hellmann, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
